Shenzhen Hosts The 2nd Agp&dtx Summit Forum: Advancing Digital Therapeutics In Diabetes Management

By Author: James Colin
Total Articles: 186
Comment this article

On July 5th, the second Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx) Summit, organized by the National Innovation Center for Advanced Medical Devices and sponsored by China AGP and DTx Digital Therapeutics R&D Center, with co-sponsorship from Shenzhen SIBIONICS Technology Co., Ltd. ("SIBIONICS"), was held in Shenzhen, China. This significant event brought together domestic and international healthcare experts to discuss the application of AGP in the precision diagnosis and treatment of diabetes, as well as the role of digital therapeutics in clinical decision-making processes worldwide.

The Summit Forum was hosted by Professor Ji Linong, the initiator of the China AGP&DTx R&D Center and a clinical professor at Peking University People's Hospital. It featured renowned endocrinology experts from various countries, including Slovenia, Australia, Saudi Arabia, Serbia, Turkey, and Algeria. These experts delved into crucial topics such as AGP consensus, the Chinese diabetes patient database, artificial pancreas systems, and digital health management. They also examined the latest advancements ...
... in diabetes management technology and its practical applications in clinical settings.

During the conference, Professor Andrej Janež, Head of the Department of Endocrinology at the Ljubljana University Medical Centre in Slovenia, praised China's progress in AGP clinical practice. He noted, "China has developed an AGP training program and is advancing into researching and utilizing AI to enhance diagnosis and guide treatment decisions, leading to improved diabetes care and facilitating AGP applications."

A notable highlight of the event was the establishment of the International Consortium for AGP&DTx R&D. This initiative aims to integrate global resources and foster innovation in diabetes diagnosis and treatment. The consortium seeks to standardize AGP clinical applications worldwide and provide a platform for international collaboration and knowledge sharing, with the ultimate goal of elevating diabetes diagnosis and treatment globally.

Experts at the summit discussed the significance of AGP, a tool that provides a comprehensive overview of glucose levels, aiding in the precise management of diabetes. The discussions underscored the importance of standardizing AGP practices to ensure consistent and accurate data interpretation across different regions. Additionally, the role of digital therapeutics was highlighted as a transformative approach in the healthcare sector, offering innovative solutions for managing chronic diseases like diabetes.

The forum emphasized the integration of AI in AGP and diabetes management, showcasing how technological advancements can revolutionize patient care. AI-driven tools can analyze vast amounts of data, providing valuable insights for personalized treatment plans. This approach not only enhances the accuracy of diagnosis but also optimizes treatment outcomes, contributing to better overall diabetes management.

Furthermore, the summit addressed the creation and utilization of a Chinese diabetes patient database, a critical resource for researchers and clinicians. This database enables the collection and analysis of extensive patient data, facilitating the development of more effective treatment strategies and the identification of trends and patterns in diabetes prevalence and management.

In conclusion, the 2nd AGP & DTx Summit in Shenzhen marked a significant milestone in the global effort to advance diabetes care. By bringing together leading experts and fostering international collaboration, the event underscored the importance of integrating innovative technologies and standardizing practices to improve diabetes diagnosis and treatment worldwide. The establishment of the International Consortium for AGP&DTx R&D represents a proactive step towards achieving these goals, promising a future where diabetes management is more precise, effective, and globally coordinated.

https://www.techdogs.com/tech-news/pr-newswire/shenzhen-hosts-the-2nd-agpdtx-summit-forum-advancing-digital-therapeutics-in-diabetes-management

Date: Jul 16, 2024

Time: 11:30